Novavax News

Novavax | 4: Statement of changes in beneficial ownership of securities-Officer Kelly James Patrick

Jan 4 06:43

Novavax | 4: Statement of changes in beneficial ownership of securities-Director Rodgers Richard J

Jan 3 05:57

Novavax | 4: Statement of changes in beneficial ownership of securities-Director King Rachel K.

Jan 3 05:51

Novavax | 4: Statement of changes in beneficial ownership of securities-Director YOUNG JAMES F

Jan 3 05:46

Novavax | 144/A: Others

Jan 3 05:08

Novavax | 8-K: Asset Purchase Agreement

Dec 31, 2024 06:30

Novavax | 144: Notice of proposed sale of securities pursuant to Rule 144

Dec 26, 2024 23:32

Novavax | 8-K: Amendment No. 5 to the Advance Purchase Agreement

Dec 19, 2024 06:29

Novavax | 4: Statement of changes in beneficial ownership of securities-Officer Casey Mark J

Dec 14, 2024 06:26

Novavax | 144: Notice of proposed sale of securities pursuant to Rule 144

Dec 14, 2024 01:16

Novavax | 8-K: Asset Purchase Agreement

Dec 4, 2024 19:07

Novavax | 8-K: Investor Presentation

Nov 21, 2024 01:57

Novavax | 3: Initial statement of beneficial ownership of securities-Officer Draghia-Akli Ruxandra

Nov 14, 2024 11:32

Novavax | 4: Statement of changes in beneficial ownership of securities-Officer Draghia-Akli Ruxandra

Nov 14, 2024 05:15

Novavax | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-The Vanguard Group(9.63%)

Nov 13, 2024 05:50

Novavax | 10-Q: Q3 2024 Earnings Report

Nov 13, 2024 05:14

Novavax | 8-K: U.S. FDA Removes Clinical Hold on Novavax's COVID-19-Influenza Combination and Stand-alone Influenza Phase 3 Trial

Nov 13, 2024 00:24

Novavax | 8-K: Novavax Reports Third Quarter 2024 Financial Results and Operational Highlights

Nov 12, 2024 22:40

Novavax | 8-K: Settlement Agreement

Nov 6, 2024 06:06

Novavax | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-The Vanguard Group(9.63%)

Nov 5, 2024 02:24